Investor Update

Basel, 26 August 2016

Anti-Cancer Agent “Xeloda®”, Obtained Approval for Additional Indication of “Adjuvant Chemotherapy for Rectal Cancer”

Dear Investor,

Please find attached a press release by Chugai.

Do not hesitate to contact us for any further questions.